To further study whether HOXA10 promoted EMT and GC metastasis through the canonical TGFβ pathway, we first treated AGS-HOXA10 cells with TGFβ/Smad signaling inhibitor HY-N0439 (MedChemExpress, USA). This evidence concerns the gene HOXA10 and gastric cancer.